SAGE Therapeutics Inc FutureCast: An R&D and Portfolio Review Transcript
Good morning everyone and thanks for joining the third annual Sage FutureCast and R&D portfolio review event. I'm Helen Rubinstein, Investor Relations at Sage.
Before we begin, I encourage everyone to go to the Investor and Media section of our website at sagerx.com, where you can find the press release related to today's call as well as the slides that we will discuss. I'd like to point out that we will be making forward-looking statements on today's call, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties and our actual results may differ materially. Please consult the risk factors discussed in today's press release and in our SEC filings for additional details.
I'll now turn the call over to Barry Greene, our Chief Executive Officer for opening remarks.
Hi, everyone. Thanks for joining us today and welcome to our third annual FutureCast and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |